BACKGROUND: A link between the provision of iron and infectious morbidity has been suggested, particularly in children with malnutrition. Two meta-analyses concluded that iron is not harmful, but malnourished children were underrepresented in most available studies. OBJECTIVE: This study evaluated the effect of iron-containing micronutrient powder (iron MNP) on infectious morbidities when provided to children with moderate-to-severe malnutrition and anemia. DESIGN: A randomized, double-blind, placebo-controlled, noninferiority safety trial using a 2-mo course of daily iron MNP or placebo powder (PP) was conducted in 268 Bangladeshi children aged 12-24 mo with moderate-to-severe malnutrition (weight-for-age z score ≤ -2) and a hemoglobin concentration between 70 and 110 g/L. The primary endpoint was a composite of diarrhea, dysentery, and lower respiratory tract infection episodes (DDL) recorded through home visits every 2 d during the intervention and then weekly for 4 mo. The noninferiority margin was 1.2. Secondary endpoints included hemoglobin and anthropometric changes at 2 and 6 mo. All deaths and hospitalizations were documented. To capture seasonal variation, the study was repeated in the winter and summer with 2 distinct groups. An intention-to-treat analysis of recurrent events was performed by using the univariate Anderson-Gill model. RESULTS: The baseline characteristics of the subjects were similar. Analysis of phase-aggregated DDL data showed that iron MNP was not inferior to PP (relative risk: 0.81; 95% CI: 0.62, 1.04) and improved hemoglobin concentrations (P < 0.0001). We recorded no deaths, and hospitalizations were rare. CONCLUSION:Iron MNP is safe and efficacious when provided to children aged 12-24 mo with moderate-to-severe malnutrition and anemia. This trial is registered at clinicaltrials.gov as NCT00530374.
RCT Entities:
BACKGROUND: A link between the provision of iron and infectious morbidity has been suggested, particularly in children with malnutrition. Two meta-analyses concluded that iron is not harmful, but malnourished children were underrepresented in most available studies. OBJECTIVE: This study evaluated the effect of iron-containing micronutrient powder (iron MNP) on infectious morbidities when provided to children with moderate-to-severe malnutrition and anemia. DESIGN: A randomized, double-blind, placebo-controlled, noninferiority safety trial using a 2-mo course of daily iron MNP or placebo powder (PP) was conducted in 268 Bangladeshi children aged 12-24 mo with moderate-to-severe malnutrition (weight-for-age z score ≤ -2) and a hemoglobin concentration between 70 and 110 g/L. The primary endpoint was a composite of diarrhea, dysentery, and lower respiratory tract infection episodes (DDL) recorded through home visits every 2 d during the intervention and then weekly for 4 mo. The noninferiority margin was 1.2. Secondary endpoints included hemoglobin and anthropometric changes at 2 and 6 mo. All deaths and hospitalizations were documented. To capture seasonal variation, the study was repeated in the winter and summer with 2 distinct groups. An intention-to-treat analysis of recurrent events was performed by using the univariate Anderson-Gill model. RESULTS: The baseline characteristics of the subjects were similar. Analysis of phase-aggregated DDL data showed that iron MNP was not inferior to PP (relative risk: 0.81; 95% CI: 0.62, 1.04) and improved hemoglobin concentrations (P < 0.0001). We recorded no deaths, and hospitalizations were rare. CONCLUSION:Iron MNP is safe and efficacious when provided to children aged 12-24 mo with moderate-to-severe malnutrition and anemia. This trial is registered at clinicaltrials.gov as NCT00530374.
Authors: Hermann B Lanou; Saskia J M Osendarp; Alemayehu Argaw; Kirrily De Polnay; Catherine Ouédraogo; Seni Kouanda; Patrick Kolsteren Journal: Matern Child Nutr Date: 2019-06-10 Impact factor: 3.092
Authors: Parminder S Suchdev; O Yaw Addo; Reynaldo Martorell; Frederick Ke Grant; Laird J Ruth; Minal K Patel; Patricia C Juliao; Rob Quick; Rafael Flores-Ayala Journal: Am J Clin Nutr Date: 2016-02-10 Impact factor: 7.045
Authors: Parminder S Suchdev; Maria Elena D Jefferds; Erika Ota; Katharina da Silva Lopes; Luz Maria De-Regil Journal: Cochrane Database Syst Rev Date: 2020-02-28
Authors: Qiong Wu; Yanfeng Zhang; Suying Chang; Wei Wang; Michelle Helena van Velthoven; Huijun Han; Min Xing; Li Chen; Xiaozhen Du; Robert W Scherpbier Journal: J Glob Health Date: 2017-06 Impact factor: 4.413
Authors: Reina Engle-Stone; Stephen A Vosti; Hanqi Luo; Justin Kagin; Ann Tarini; Katherine P Adams; Caitlin French; Kenneth H Brown Journal: Ann N Y Acad Sci Date: 2019-06-06 Impact factor: 5.691